Literature DB >> 686867

Studies on cold insoluble globulin. I Concentrations in citrated plasma in rheumatic disorders.

O Fyrand, E Munthe, N O Solum.   

Abstract

Cold insoluble globulin (CIG) is a normal glycoprotein of human serum and plasma. The physiological significance of this protein is unknown, but is shows a temperature-dependent relation to fibrinogen and fibrin. It is possible that it represents a substrate for activated fibrin-stabilising factor in the polymerisation of fibrin. CIG is found on the surface of fibroblasts. In the present study CIG was estimated in citrated plasma in 115 patients with rheumatic diseases. Increased amounts were found in patients with systemic lupus erythematosus, secondary amyloidosis in classical and definite rheumatoid arthritis, and in male patients with juvenile rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 686867      PMCID: PMC1000242          DOI: 10.1136/ard.37.4.347

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Studies on cold insoluble globulin in dermatological patients. I. Immunochemical quantitation in citrated plasma from patients with increased amounts of heparin precipitable fraction (HPF).

Authors:  O Fyrand; N L Solum
Journal:  Thromb Res       Date:  1976-11       Impact factor: 3.944

2.  Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus.

Authors:  A Vaheri; E Ruoslahti
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

3.  Variation of the concentrations of some plasma proteins in normal adults, in pregnant women and in newborns.

Authors:  P O Ganrot
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

4.  Plasma protein pattern in cirrhosis of the liver.

Authors:  J Hällén; C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Composition and variation of the gel electrophoretic fractions of plasma, cerebrosinal fluid and urine.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

6.  Sequential changes of plasma proteins after myocardial infarction.

Authors:  B G Johansson; C O Kindmark; E Y Trell; F A Wollheim
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

7.  Sequential changes of plasma proteins after surgical trauma.

Authors:  K F Aronsen; G Ekelund; C O Kindmark; C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

8.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

9.  Amyloid production by dermal fibroblasts. Electron microscopic studies on the origin of amyloid in various dermatoses and skin tumours.

Authors:  U Runne; C E Orfanos
Journal:  Br J Dermatol       Date:  1977-08       Impact factor: 9.302

10.  Studies on cold insoluble globulin in dermatological patients. II. Its immunochemical quantitation in citrated plasma in a group of unselected dermatological inpatients.

Authors:  O Fyrand
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

View more
  7 in total

1.  Fibronectin in chronic inflammation: studies using the rat air pouch model of chronic allergic inflammation.

Authors:  D L Scott; M W Robinson; S Yoshino
Journal:  Br J Exp Pathol       Date:  1985-10

2.  Fibronectin in exudative pleural effusions.

Authors:  M Klockars; T Pettersson; T Vartio; H Riska; A Vaheri
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

3.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15

4.  Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease.

Authors:  John H Peters; Tammy Greasby; Nancy Lane; Anthony Woolf
Journal:  Biomarkers       Date:  2009-06       Impact factor: 2.658

5.  Significance of fibronectin in rheumatoid arthritis and osteoarthrosis.

Authors:  D L Scott; A C Wainwright; K W Walton; N Williamson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

6.  Differences between plasma and synovial fluid fibronectin.

Authors:  D L Scott; S D Carter; J S Coppock; M Robinson; K W Walton
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

7.  Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.

Authors:  L Puccetti; G Marotta; E Remorini; A Lucchetti; M Zuccotti; G Petrini; U Baicchi; M L Ciompi
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.